Procarbazine 50 MG Oral Capsule [Matulane] — RxCUI 207588
RxNorm drug concept · Semantic branded drug
RxCUI 207588
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI207588
Official nameProcarbazine 50 MG Oral Capsule [Matulane]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMatulane 50 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Procarbazine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Matulane is a chemotherapy medicine used to treat Stage III and IV Hodgkin's disease — a cancer of the lymphatic system that has spread significantly. It's not taken alone; it's al...
- For most people starting Matulane, yes — nausea and vomiting are the most common side effects, especially in the first week. The dosing approach is actually designed to start lower...
- Are nausea and vomiting going to be a big problem?
- Procarbazine mildly blocks an enzyme called MAO (monoamine oxidase), which normally breaks down certain chemical messengers in your body. Alcohol can cause a severe reaction — flus...
🕸️ Concept Web — How Procarbazine 50 MG Oral Capsule [Matulane] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Procarbazine 50 MG Oral Capsule [Matulane]
RxCUI 207588 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Procarbazine
8702IN
-
Procarbazine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Matulane
203801BN
-
Matulane
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Procarbazine Oral Capsule
373602SCDF -
Procarbazine Oral Product
1161732SCDG -
Procarbazine Pill
1161733SCDG -
Procarbazine Oral Capsule [Matulane]
366728SBDF -
Matulane Oral Product
1181565SBDG -
Matulane Pill
1181566SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Procarbazine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Procarbazine 50 MG Oral Capsule
314167SCD -
Procarbazine 50 MG
328546SCDC -
Procarbazine 50 MG [Matulane]
568345SBDC
-
Procarbazine 50 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Procarbazine 50 MG Oral Capsule
SCD · 314167 -
Procarbazine 50 MG
SCDC · 328546 -
Procarbazine Oral Capsule
SCDF · 373602 -
Procarbazine Oral Product
SCDG · 1161732 -
Procarbazine Pill
SCDG · 1161733
Brand-Name Concepts
-
Procarbazine 50 MG [Matulane]
SBDC · 568345 -
Procarbazine Oral Capsule [Matulane]
SBDF · 366728 -
Matulane Oral Product
SBDG · 1181565 -
Matulane Pill
SBDG · 1181566 -
Matulane
BN · 203801
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 207588 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 54482-0054-01 | 100 CAPSULE in 1 BOTTLE (54482-054-01) | Matulane | Leadiant Biosciences, Inc. | 1985-12-27 |
Observed labelers:
Leadiant Biosciences, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.